Emphysema Protease-Antiprotease Imbalance Module

Toxicology Module emphysema_protease_antiprotease_imbalance 2 disorders Pathograph 5

A conserved alveolar-destruction module representing the protease-antiprotease and oxidant-antioxidant imbalance paradigm that underlies pulmonary emphysema. Inhaled oxidants and particulates (chiefly cigarette smoke) or a genetic deficiency of alpha-1 antitrypsin trigger chronic lower-airway inflammation with recruitment of macrophages and neutrophils. The activated phagocytes release excess serine proteases (neutrophil elastase) and matrix metalloproteinases that overwhelm endogenous antiprotease defenses, producing proteolytic destruction of the alveolar-wall extracellular matrix, especially the elastic fiber network. Loss of elastin and collagen distends and ruptures alveolar walls, reducing elastic recoil and gas-exchange surface area. The acquired (smoking-related COPD) and inherited (alpha-1 antitrypsin deficiency) routes converge on this final common pathway, the permanent enlargement of distal airspaces with alveolar destruction that defines emphysema. Conforming disorder entries substitute the disorder-specific initiating insult (oxidant load versus antiprotease deficiency) while preserving the conserved causal chain.

⚙

Pathophysiology Nodes

5 shared nodes are defined in this module.

◉

Cell Types

⇄

Biological Processes

Inflammatory Response GO:0006954 INCREASED Response to Oxidative Stress GO:0006979 INCREASED Leukocyte Migration GO:0050900 INCREASED Proteolysis GO:0006508 INCREASED Extracellular Matrix Disassembly GO:0022617 INCREASED Apoptotic Process GO:0006915 INCREASED

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "emphysema_protease_antiprotease_imbalance#Protease-Antiprotease Imbalance"). Key disorder-specific substitutions conforming nodes should make: cigarette-smoke COPD-emphysema enters through oxidant/particulate-driven inflammation with relatively normal alpha-1 antitrypsin levels, whereas alpha-1 antitrypsin deficiency (PiZZ/PiSZ) enters through a primary antiprotease deficit; both converge on unopposed proteolysis of the alveolar wall. Conforming nodes may substitute alveolar macrophage (CL:0000583) for the generic macrophage where the alveolar compartment is emphasized.

↗

Used By Disorder Entries

Alpha-1 Antitrypsin Deficiency via Protease-Antiprotease Imbalance in Lung → Protease-Antiprotease Imbalance

Chronic_Obstructive_Pulmonary_Disease via Protease-Antiprotease Imbalance (MMP-2/TIMP-2 Axis) → Protease-Antiprotease Imbalance

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.

⚙

Pathophysiology

Oxidant and Inflammatory Trigger

trigger

Inhaled oxidants and particulates (predominantly cigarette smoke), or in the inherited route a genetic deficiency of alpha-1 antitrypsin, initiate and sustain chronic inflammation of the lower airways and alveoli. This inflammatory program recruits and activates alveolar macrophages and neutrophils, accompanied by a high level of oxidative stress that amplifies the response. This is the conserved upstream trigger from which both the acquired smoking-related and inherited deficiency routes proceed.

Alveolar macrophage CL:0000583 Neutrophil CL:0000775

Inflammatory Response GO:0006954 INCREASED Response to Oxidative Stress GO:0006979 INCREASED Leukocyte Migration GO:0050900 INCREASED

Downstream

Protease-Antiprotease Imbalance

Protease-Antiprotease Imbalance

amplifier

Activated neutrophils and macrophages release excess serine proteases, chiefly neutrophil elastase, and matrix metalloproteinases. In the acquired route, oxidant inactivation of alpha-1 antitrypsin plus an increased protease burden tips the balance; in the inherited route, severe alpha-1 antitrypsin deficiency leaves elastase unopposed. Across both, the net result is excess unopposed protease activity relative to endogenous antiprotease defenses. This is the central amplifying lesion of the module.

Neutrophil CL:0000775 Alveolar macrophage CL:0000583

Proteolysis GO:0006508 INCREASED

Used by disorders

Alpha-1 Antitrypsin Deficiency as Protease-Antiprotease Imbalance in Lung

Chronic_Obstructive_Pulmonary_Disease as Protease-Antiprotease Imbalance (MMP-2/TIMP-2 Axis)

Downstream

Alveolar ECM and Elastin Destruction

Alveolar ECM and Elastin Destruction

central effector

Unopposed proteolysis degrades the extracellular matrix of the alveolar wall, with the elastic fiber network surrounding the airspaces being the critical target. Elastolysis and breakdown of collagen disrupt the load-bearing matrix that stores the energy needed for normal expiration. This is the central effector step that translates the biochemical imbalance into structural matrix loss.

Extracellular Matrix Disassembly GO:0022617 INCREASED

Downstream

Alveolar Wall Destruction and Airspace Enlargement

Alveolar Wall Destruction and Airspace Enlargement

effector

Progressive loss of the elastic and collagenous matrix leads to distension and rupture of alveolar walls, with loss of elastic recoil and a reduction in the gas-exchange surface area. Alveolar wall cells are lost through injury and apoptosis, and adjacent airspaces coalesce. The result is the structural hallmark of emphysema preceding the named clinical phenotype.

Apoptotic Process GO:0006915 INCREASED

Downstream

Emphysema

Emphysema

consequence

The permanent enlargement of the distal airspaces (distal to the terminal bronchioles) accompanied by destruction of their walls, without obvious fibrosis. This is the named disease-like phenotype that the protease- antiprotease and oxidant-antioxidant imbalance cascade converges upon, shared by cigarette-smoke COPD-emphysema and genetic alpha-1 antitrypsin deficiency. The clinical consequence is airflow limitation with reduced elastic recoil and impaired gas exchange.